Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech
Best Cardiac CT Analytics Platforms Companies
What is Cardiac CT Analytics Platforms?
The cardiac CT analytics platforms market is focused on improving the diagnosis and management of heart disease through the use of artificial intelligence and advanced imaging technologies. Companies in this market use tech to accurately detect and analyze features such as coronary artery stenosis, ventricular hypertrophy, and other anomalies that can be indicative of cardiac-related diseases. Tech-powered systems can also be used to quantify the volume and composition of plaque, as well as to measure the size and shape of the heart chambers. Current diagnostic methods, such as risk factor evaluation and stress tests, have limitations in detecting coronary artery disease (CAD) and can lead to incorrect diagnoses, unnecessary invasive procedures, and expensive medical therapies. The cardiac CT analytics platforms market has the potential to revolutionize the way heart disease is diagnosed and managed, ultimately improving patient outcomes and reducing healthcare costs.
Expert Collections
Market Map
Similar Markets
Do you compete within Cardiac CT Analytics Platforms?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.
Top Cardiac CT Analytics Platforms Companies

Cleerly is a digital healthcare company focused on the diagnosis and treatment of heart disease through its solutions in the cardiovascular care sector. The company offers a digital care platform that uses non-invasive CT imaging to identify and quantify atherosclerosis, enabling treatment plans for heart disease. Cleerly's technology aims to provide phenotyping of coronary artery disease, improving the accuracy of heart attack risk assessments and supporting clinical decision-making. It was founded in 2017 and is based in Denver, Colorado.
Known Partners
Known Customers
Key People
James Min, Joseph Jasser, Nick Nieslanik, and 2 more

Ultromics operates within the medical technology industry and focuses on heart failure detection. The company offers diagnostic tools that analyze echocardiograms to identify conditions such as heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing clinicians with reports to assist in clinical decisions. Ultromics serves healthcare providers, including hospitals and clinics, by integrating its technology into existing medical imaging workflows. It was founded in 2017 and is based in Oxford, England.
Known Partners
Subscribe, Subscribe, Subscribe, and 2 more
Known Customers
Subscribe
Key People
Subscribe, Subscribe, Subscribe

HeartFlow provides a digital health service platform for heart disease diagnosis and treatments. It offers a non-invasive personalized cardiac test that provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create treatment plans for their patients. HeartFlow was formerly known as Cardiovascular Simulation. It was founded in 2010 and is based in Mountain View, California.
Known Partners
Subscribe, Subscribe, Subscribe, and 2 more
Known Customers
Subscribe
Key People
Subscribe, Subscribe, Subscribe, and 2 more
All Companies in Cardiac CT Analytics Platforms

Artrya serves as a healthcare technology company that utilizes AI to analyze coronary computed tomography angiography (CCTA) for the assessment and stratification of chest pain patients in emergency and primary settings. The company's solutions are designed to support the diagnosis, treatment, and prevention of coronary artery disease. It was founded in 2019 and is based in West Perth, Australia.
Known Partners
Subscribe, Subscribe, Subscribe
Known Customers
Subscribe

BrainSightAI offers AI-based solutions such as VoxelBox and Snowdrop, which provide clinicians with tools for generating personalized brain maps and supporting clinical decision-making. VoxelBox includes an fMRI processing engine and machine-learning models, while Snowdrop is a patient care app that helps with treatment schedules and develops a patient profile. BrainSightAI was formerly known as Brainsight. It was founded in 2019 and is based in Bangalore, India.
Known Partners
Subscribe
Key People
Subscribe, Subscribe

Caristo Diagnostics specializes in cardiovascular diagnostic tools within the healthcare technology sector. The company enhances the accuracy of routine cardiac computed tomography scans by identifying coronary inflammation and other hidden cardiac issues, which improves the prediction of cardiovascular risk and aids in treatment decisions. Its technology is utilized in preventive screening, disease diagnosis, intervention planning, and clinical research. The company was founded in 2017 and is based in Oxford, United Kingdom.
Known Partners
Subscribe
Known Customers
Subscribe
Key People
Subscribe, Subscribe

Idoven is a health technology company that focuses on detection and medicine in the cardiovascular domain. The company offers an artificial intelligence (AI)-powered platform that improves the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and works with existing ECG devices to support clinician decision-making and disease management. It was founded in 2018 and is based in Madrid, Spain.
Known Partners
Subscribe, Subscribe, Subscribe, and 2 more
Key People
Subscribe, Subscribe, Subscribe, and 2 more

Medipixel develops artificial intelligence (AI)-based cardiovascular disease diagnosis and treatment solutions. The company's main offerings include an AI-based diagnosis solution that helps doctors identify and analyze lesions, a guide and planning solution that aids in guidewire manipulation, and an automated navigation engine for device delivery within coronary arteries. It primarily serves the healthcare sector. The company was founded in 2017 and is based in Seoul, South Korea.
Known Customers
Subscribe, Subscribe
Key People
Subscribe, Subscribe, Subscribe, and 1 more

United States / Founded Year: 0000
Myocardial Solutions is a medical technology company focused on transforming cardiac and cancer care with its proprietary technology in the healthcare sector. The company's main offering is MyoStrain®, a non-invasive, MRI-enhanced cardiac software that provides a rapid and accurate 10-minute heart health assessment to help physicians detect and manage early cardiac dysfunction. MyoStrain® is primarily utilized in the healthcare industry, offering a novel clinical tool for the early assessment and individualized treatment of heart dysfunction, particularly in the context of cardiotoxicity during cancer treatments. It was founded in 2016 and is based in Morrisville, North Carolina.
Known Partners
Subscribe, Subscribe
Key People
Subscribe, Subscribe

Shukun Technology provides smart medical and health technology platform services. The company offers a suite of artificial intelligence-powered diagnostic assistance products that cover common and significant diseases across various human body parts. Shukun Technology also provides comprehensive solutions for medical imaging, surgical planning, and health management, leveraging multimodality technology and original research to serve the healthcare industry. It was founded in 2017 and is based in Beijing, China.
Known Partners
Subscribe, Subscribe, Subscribe, and 4 more
Key People
Subscribe, Subscribe, Subscribe
Our Methodology
The ESP matrix leverages data and analyst insight to identify and rank leading private-market companies in a given technology landscape.
What is Cardiac CT Analytics Platforms?
The cardiac CT analytics platforms market is focused on improving the diagnosis and management of heart disease through the use of artificial intelligence and advanced imaging technologies. Companies in this market use tech to accurately detect and analyze features such as coronary artery stenosis, ventricular hypertrophy, and other anomalies that can be indicative of cardiac-related diseases. Tech-powered systems can also be used to quantify the volume and composition of plaque, as well as to measure the size and shape of the heart chambers. Current diagnostic methods, such as risk factor evaluation and stress tests, have limitations in detecting coronary artery disease (CAD) and can lead to incorrect diagnoses, unnecessary invasive procedures, and expensive medical therapies. The cardiac CT analytics platforms market has the potential to revolutionize the way heart disease is diagnosed and managed, ultimately improving patient outcomes and reducing healthcare costs.
Expert Collections
Market Map
Similar Markets
Do you compete within Cardiac CT Analytics Platforms?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.